Clinical trials
Completed Carcinoma, Transitional Cell trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2015 | 2 |
| 2016 | 6 |
| 2017 | 4 |
| 2018 | 4 |
| 2019 | 6 |
| 2020 | 2 |
| 2022 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 32 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Spanish Oncology Genito-Urinary Group | 3 |
| Bayer | 2 |
| Bristol-Myers Squibb | 2 |
| Eli Lilly and Company | 2 |
| Hoffmann-La Roche | 2 |
| Incyte Corporation | 2 |
| Nektar Therapeutics | 2 |
| Achieve Life Sciences | 1 |
| Acrotech Biopharma Inc. | 1 |
| Adaptimmune | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Transitional Cell | 32 |
| Urinary Bladder Neoplasms | 15 |
| Neoplasm Metastasis | 9 |
| Carcinoma, Non-Small-Cell Lung | 8 |
| Melanoma | 5 |
| Neoplasms | 5 |
| Carcinoma, Renal Cell | 4 |
| Stomach Neoplasms | 4 |
| Carcinoma, Hepatocellular | 3 |
| Triple Negative Breast Neoplasms | 3 |
Trials
Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.